Myles J. Lewis

Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial

R. Moots, P. McKeigue, J. Isaacs, 2022, Nature Medicine.

Synovial fibroblast gene expression is associated with sensory nerve growth and pain in rheumatoid arthritis

D. Orange, M. Frank, A. Malfait, 2024, Science Translational Medicine.

Metabolic reprogramming by Syntenin-1 directs RA FLS and endothelial cell-mediated inflammation and angiogenesis

M. Volin, N. Sweiss, S. Shahrara, 2023, Cellular & molecular immunology.

Autoimmunity to stromal-derived autoantigens in rheumatoid ectopic germinal centers exacerbates arthritis and affects clinical response

A. Pitsillides, M. Bombardieri, B. Javaheri, 2024, The Journal of clinical investigation.

Investigation of genetically regulated gene expression and response to treatment in rheumatoid arthritis highlights an association between IL18RAP expression and treatment response

J. Barrett, A. Barton, M. Barnes, 2020, Annals of the Rheumatic Diseases.

Analgesic targets identified in mouse sensory neuron somata and terminal pain translatomes

C. Çubuk, S. Santana-Varela, Samuel J. Gossage, 2024, bioRxiv.

Senescent endothelial cells promote pathogenic neutrophil trafficking in inflamed tissues

S. Nourshargh, M. Voisin, C. Bishop, 2024, EMBO reports.